These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 4930184)
1. [Necessity of clinically controlled studies for the development of new drugs]. Lüthy E; Joyce CR Ther Umsch; 1971 Apr; 28(4):246-9. PubMed ID: 4930184 [No Abstract] [Full Text] [Related]
2. Clinical trial design in metastatic breast cancer: a commentary. Levine M Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523 [TBL] [Abstract][Full Text] [Related]
3. Principles for the clinical evaluation of drugs. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser; 1968; 403():1-32. PubMed ID: 4972959 [No Abstract] [Full Text] [Related]
4. [Planning of clinical studies based on results of animal experiments]. Radielović P Med Arh; 1972; 26(3):39-42. PubMed ID: 4562219 [No Abstract] [Full Text] [Related]
5. New drugs with novel therapeutic characteristics. Have they been subject to randomized controlled trials? Lexchin J Can Fam Physician; 2002 Sep; 48():1487-92. PubMed ID: 12371307 [TBL] [Abstract][Full Text] [Related]
7. Limitations of controlled double-blind studies of drugs. Cotzias GC N Engl J Med; 1972 Nov; 287(18):937. PubMed ID: 4561673 [No Abstract] [Full Text] [Related]
8. [Pharmacotherapy, its progress and the problems it poses]. Martin E Pharm Acta Helv; 1968 Sep; 43(9):606-18. PubMed ID: 4887986 [No Abstract] [Full Text] [Related]
9. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic evaluations of new drugs for epileptics. Nelemans FA Psychiatr Neurol Neurochir; 1971; 74(2):137-40. PubMed ID: 4948426 [No Abstract] [Full Text] [Related]
12. The Challenge of Developing New Therapies for Childhood Cancers. Balis FM Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032 [TBL] [Abstract][Full Text] [Related]
13. [Clinical drug research in children: current international guidelines. Committee for Proprietary Medicinal Products]. Ruys-Dudok van Heel I; Cohen AF; Wit JM; van der Heijden AJ; van den Anker JN; van Meurs AH Ned Tijdschr Geneeskd; 1998 Jan; 142(1):6-9. PubMed ID: 9556981 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of generalized anxiety: new pharmacologic approaches]. Boulenger JP Encephale; 1995; 21(6):459-66. PubMed ID: 8674471 [TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of new drugs. Experiences with application procedures]. Liljestrand A; Nordlander M Nord Med; 1970 Sep; 84(38):1204. PubMed ID: 4918866 [No Abstract] [Full Text] [Related]
18. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection. Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760 [TBL] [Abstract][Full Text] [Related]
19. Alternative strategies in drug development: clinical pharmacological aspects. Kuhlmann J Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949 [TBL] [Abstract][Full Text] [Related]
20. Criteria supporting the study of drugs in the newborn. Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]